Abstract
Background
Dendrobium amoenum is known for its aesthetic and medicinal values but it is threatened due to loss of wild resources. Plant tissue culture promotes wild resource protection and paves the way for secondary metabolite production. In this study, protocorms developed via in-vitro seed cultivation were used for bioactive secondary metabolite production. The objectives of this study were to evaluate total phenolic and flavonoid contents, to identify the bioactive secondary metabolites, to explore the antioxidants and cytotoxic properties of in-vitro-derived protocorms extracts of D. amoenum.
Methods
Seeds of D. amoenum were cultivated on 10% coconut water, 0.25 and 0.5 mg/L BAP supplemented full-strength and half-strength MS medium to produce protocorms for the isolation of bioactive components. A distinct yellow fraction (DAYF), light-green fraction (DALGF), green fraction (DAGF), and dark-green fraction (DADGF) were obtained from methanol extract on a methanol-based Sephadex LH-20 column. The total phenol and flavonoid contents along with the antioxidant and cytotoxic properties of the fractions were evaluated. The compounds in active DAYF were identified using a GC-MS.
Results
On a full-strength solid MS medium supplemented with 10% coconut water, approximately 95% of the seeds grew into protocorms, while 88.33% did so on a full-strength liquid MS medium. The DAYF had a total phenol content of 206.38 μg of GAE and a total flavonoid content of 101.88 μg of QE. Owing to these high contents, the DAYF inhibited 50% of the DPPH free radicals at a concentration of 63.73 μg/ml. Similarly, it also reduced the growth of HeLa cells by 50% at 67.03 μg/ml and U2OS cells by 50% at 207.40 μg/ml, while it was nontoxic to normal human epithelium cells. Bioactive phenolic compounds 2-methoxy-4-vinylphenol (1), 3,4-dimethoxy-phenol (2), 2-methoxy-4-(1-propenyl)-phenol (3), 2,6-dimethoxy-4-(2-propenyl)-phenol (4), 3-methoxy-1,2-benzenediol (5) were identified in the DAYF.
Conclusion
Protocorms of D. amoenum could serve as sources of bioactive secondary metabolites highlighting their potential in alternative medicine.
Keywords: Cancer cells, DPPH assay, Flavonoid, MTT assay, Phenol, Protocorms
Background
Dendrobium is a highly significant orchid genus known for its aesthetic and medicinal value. The genus has a wide distribution ranging from tropical to temperate regions in Asia to Australia and the Pacific, showing impressive species diversity with approximately 1,800 different species exhibiting variations in size, shape, structure, colour and fragrance [1]. In Nepal, there are 30 different Dendrobium species, including D. amoenum Wall. ex Lindl. stand out as a prominent epiphytic orchid found in the Central and Eastern regions at altitudes ranging from 1100 to 2900 m above sea level [2]. This species is highly stared for its beautiful blossoms and medicinal properties, as its stems are used as a tonic for remedies for stomachache, antipyretic, heart diseases, etc. in traditional Chinese medicine [3]. Several compounds including amoenylin, isoamoenylin, moscatilin, bibenzyl derivatives, phenols, phenanthrenes, and sesquiterpenoids have been isolated from D. amoenum and exhibit antioxidant properties [4–6]. The phenolic and flavonoid content-rich extracts of its stems have antioxidant activity [7]. Studies have revealed that the crude extract of D. amoenum contains antioxidants that have cytotoxic effects on human cervical cancer and glioblastoma cells [8].
Plant tissue culture has attracted much attention for plant regeneration and conservation as well as plant-specific bioactive compound production [9]. This technology promotes wild resource protection, promotes the industrialization of plant propagation in horticulture, and provides raw materials applicable to the pharmaceutical industry [10]. Some studies have even emphasized the use of in-vitro tissue culture to produce secondary metabolites [9, 11–13]. Protocorms are highly accumulated tissue developed via in-vitro seed cultivation and are a source of bioactive secondary metabolites [12, 14, 15]. This study used the tissue culture method for the accumulation of bioactive compounds in protocorms via the cultivation of D. amoenum seeds, which could be used as a valuable approach for pharmaceutical industrial production without damaging its wild resources. The objectives of this study were to evaluate the total phenol and flavonoid contents in the protocorms, to identify compounds in the protocorms, and to evaluate the antioxidant and cytotoxic properties of protocorms. In addition, the ability of the medium to respond quickly to seed germination and the development of protocorms was studied, which not only provides a new idea for the accumulation of potentially bioactive compounds in protocorms and seedlings but also lays a foundation for plant regeneration for the conservation of wild resources.
Materials and methods
Plant materials collection, sterilization and seed culture
The mature capsule of Dendrobium amoenum was collected from Nagarkot in the Bhaktapur district of Nepal (27.7236° N, 85.5247° E). Plant was identified by two authors Prof. Dr. Bijaya Pant and Dr. Mukti Ram Paudel. The voucher specimen of the plant’s herbarium was deposited in the Tribhuvan University Central Herbarium (TUCH). The voucher number of this herbarium is DA01. The permission for the plant collection was obtained from the Department of Forest and Soil Conservation of the Ministry of Forest and Environment, Government of Nepal. The capsule was thoroughly washed under running water with 4–5 drops of Tween-20 for 45 min to remove surface dirt. The capsules were then submerged in a 1% sodium hypochlorite solution for 15 min, followed by rinsing with sterile water. The capsule was then immersed in 70% ethanol for 3–5 min and rinsed three more times with sterile water to ensure complete surface sterilization. The powdery seeds extracted from the sterilized capsule were thinly sown on full- and half-strength of Murashige and Skoog (MS) medium each supplemented with 0.25 and 0.5 mg/L of BAP and 10% coconut water, and in full-strength MS liquid medium. Agar-agar (8 g/L) is used to solidify the MS medium. To maintain sterility and prevent bacterial or fungal contamination, all procedures were performed in a laminar airflow cabinet with a flame. The cultured jars containing the seeds were transferred to an incubation room with controlled conditions of 25 ± 2ºC, 78 ± 5% humidity and a photoperiod of 12–16 h. The growth and development of protocorms from seeds were carefully monitored and recorded, and subcultured regularly for protocorms production throughout the incubation period (12 months long).
Preparation of extract and fractions from protocorms
In-vitro cultivated 12-month-old protocorms (approximately 200 g collected from all treatments) were properly shade-dried at room temperature. The dried protocorms were ground into a fine powder and subjected to 72 h of maceration in 90% methanol, effectively extracting the active phytochemicals. Following maceration, the mixture was filtered to collect the methanol filtrate. The crude methanol extract was then concentrated via a rotary evaporator (Eyela, Japan).
The crude methanol extract was subsequently fractionated via a methanol-based Sephadex LH-20 column. Distinct colour bands were collected separately: the yellow fraction (DAYF), light-green fraction (DALGF), green fraction (DAGF), and dark-green fraction (DADGF). Each fraction was further concentrated via a rotary evaporator under reduced pressure at temperatures below 40 °C to prevent the degradation of active compounds and to remove any remaining solvent, resulting in a dry form. The dried fractions were then accurately weighed and stored at 4 °C.
Determination of total phenolic content
The total phenolic content in the methanol fractions was measured using the Folin-Ciocalteau (FC) colourimetric method [16]. Either the fraction sample (1 mg/ml) or gallic acid (0–100 μg/ml) in 75 μl of distilled water was placed in a 96-well plate, followed by the addition of 25 μl of the FC reagent (diluted 1:1 with distilled water). After a 6-minute incubation, 100 μl of 1 M aqueous Na2CO3 was added. Absolute methanol was used as the blank. Following a 90-minute incubation at room temperature, the absorbance at 765 nm was measured via a microplate reader (Azure Biosystems). The total phenolic content was calculated via a linear equation observed based on the absorbance of gallic acid at different concentrations (0–100 μg/ml) and expressed as micrograms of gallic acid equivalent per gram of fraction (μg GAE/gm).
Determination of total flavonoid content
The total flavonoid content was determined using the aluminium chloride (AlCl3) colourimetric technique [17]. First, 250 μl of the methanol fraction (1 mg/ml) was mixed with 750 μl of 10% AlCl3 and 50 μl of 1 M potassium acetate. The mixture was then diluted with 1.4 ml of distilled water and allowed to stand at room temperature for 30 min. Absolute methanol was used as the blank. The reaction mixture (200 μl) was transferred in triplicate to a 96-well plate, and the absorbance was measured at 415 nm via a microplate reader (Azure Biosystems). The total flavonoid content was calculated via a linear equation derived from the absorbance of quercetin at different concentrations (0–100 μg/ml in methanol) and expressed as micrograms of quercetin equivalent (μg QE/gm) per gram of fraction.
Evaluation of antioxidant activity
The antioxidant activity was assessed via a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay with slight modification [18]. A 0.2 mM DPPH solution (7.88 mg of DPPH in 100 ml of methanol) was prepared and stored away from direct sunlight. In a 96-well plate, 50 μl of each fraction (at concentrations ranging from 25 to 200 μg/ml in methanol) was mixed with 150 μl of the DPPH solution. Absolute methanol served as the control. After 30 min of incubation at room temperature in the dark, the absorbance of the reaction mixture was measured at 517 nm via a microplate reader (Azure Biosystems). The fraction with the lowest absorbance presented the highest antioxidant activity. The free radical scavenging activity of the samples was calculated via the following equation:
![]() |
The percentage of radical scavenging activity was plotted on the Y-axis against the concentration on the X-axis. The IC50 value (in μg/ml), which represents the maximal inhibitory concentration required to inhibit 50% of the DPPH radicals, was determined via the linear equation derived from the plot, which was used to determine the antioxidant capacity of the fraction.
Evaluation of the cytotoxic activity
A modified MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) colourimetric was used to evaluate the cytotoxic effects of methanol fractions on three cell lines: a normal epithelial human cell line and two cancer cell lines (HeLa and U2OS). The cell lines were cultured in Eagle minimum essential medium (EMEM) supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin and 1% L-glutamine, and incubated at 37 °C in 5% CO2. Once 80% confluency was reached, approximately 10,000 cells in the culture medium were transferred to a 96-well plate and incubated for 24 h. The cells were then treated with different concentrations (25, 50, 100 and 200 μg/ml) of methanol fractions and incubated for 48 h. About 10 μl of 5 mg/ml MTT reagent was added to treated cells, and incubated for 4 h. After a 4-hour incubation with the MTT reagent, purple formazan crystals formed. The formazan crystals were dissolved in dimethyl sulfoxide (DMSO), and the absorbance was measured at 595 nm via a microplate reader (Azure Biosystems). The cytotoxic effect of the fractions was assessed by calculating the percentage of cell death compared with that of the control. The IC50 value, which is the maximal inhibitory concentration of the fraction that reduces cell growth by 50%, was determined from the dose-response curve of the percentage of cytotoxic activity. The percentage of cytotoxic activity was calculated via the following formula:
![]() |
Identification of compounds in the yellow fraction
The compounds in the yellow fraction (DAYF) were identified via a GC-MS-QP2010 Ultra (Shimadzu Europa GmbH, Germany). Owing to their moderate or negligible cytotoxic activity, other fractions were not subjected to GC-MS. The GC-MS employed an electron ionization system with high-energy electrons (70 eV) for spectroscopic detection. The carrier gas was 99.99% pure helium, which flowed at a rate of 0.95 millilitres per minute. The initial temperature was set at 100 °C, held for 10 min, and then increased at a rate of 3 °C per minute. A splitless injection of one microliter of the 1% fraction diluted in methanol was performed. The relative quantity of the compounds was expressed as a percentage of the peak area generated in the chromatogram. The compounds were identified by comparing their spectra with those of the established standards library and using the GC retention times.
Statistical analysis
The time required for protocorm formation (in weeks) and the percentage of seed germination in the culture medium are expressed as the mean ± standard error. The Duncan test (p ≤ 0.05) was used to determine significant differences in seed germination and protocorm development across different media. This test was also applied to evaluate significant differences in total phenol and flavonoid contents, IC50 values of antioxidant activity, and the growth of HeLa, U2OS, and normal cells across different fractions. All the statistical analyses were performed via IBM SPSS v.20.
Results
In-vitro seed germination and protocorm formation
The germination of seeds and their development into protocorms significantly differed across various strengths of MS solid and liquid medium supplemented with BAP (0.25 and 0.5 mg/L) and 10% coconut water (Table 1). Among the tested media, 88.33% of the seeds germinated in MS liquid medium (LMS), with protocorms developing in an average of 5.67 weeks (approx. 5 weeks and 4 days). Additionally, protocorms developed within 6 weeks on a full-strength MS medium (FMS) supplemented with 10% coconut water (CW), where 95% of the seeds germinated (Fig. 1). The lowest seed germination rate (20%) was observed on a half-strength MS medium (HMS) supplemented with 0.25 mg/L BAP. Protocorms on FMS and HMS supplemented with 0.25 mg/L BAP developed after 10 weeks of seed culture. The results indicate that FMS supplemented with 10% CW and LMS are most suitable for developing protocorms from seeds.
Table 1.
In vitro seed germination percentage and protocorm formation
| Medium | Protocorm formation (weeks) (Mean ± SE) | Germination percentage (Mean ± SE) |
|---|---|---|
| FMS | 7.00 ± 0.00b | 83.33 ± 0.16b |
| HMS | 7.83 ± 0.16b | 66.67 ± 0.33c |
| LMS | 5.67 ± 0.33a | 88.33 ± 1.67a |
| FMS + 10%CW | 6.00 ± 0.00a | 95.00 ± 0.00a |
| HMS + 10%CW | 7.33 ± 0.33b | 78.33 ± 1.67b |
| FMS + 0.25BAP | 10.33 ± 0.33d | 23.33 ± 1.67f |
| FMS + 0.5BAP | 9.33 ± 0.33c | 41.67 ± 1.67d |
| HMS + 0.25BAP | 10.67 ± 0.33d | 20.00 ± 0.00f |
| HMS + 0.5BAP | 7.33 ± 0.33b | 31.67 ± 1.67e |
The values in a column with different letters are significantly different at p ≤ 0.05 (Duncan test, n = 6)
Fig. 1.
Protocorms developed on full-strength MS media supplemented with 10% coconut water
Total flavonoid and phenolic contents
The methanol fractions presented significant differences in total flavonoid and phenolic contents. The yellow fraction (DAYF) had the highest total flavonoid content (101.88 μg of QE/mg extract), whereas the dark-green fraction (DADGF) had the lowest total flavonoid content (35.21 μg of QE/mg extract). Similarly, the highest total phenolic content was found in the DAYF (206.38 μg of GAE/mg extract), whereas the DADGF had the lowest total phenolic content (74.80 μg of GAE/mg extract) (Table 2). This study revealed that the DAYF had significantly the highest total flavonoid and phenolic contents than other fractions.
Table 2.
Total flavonoid and total phenolic contents in the methanol extract fractions
| Fraction of methanol extract | Total flavonoid content (μg QE/mg extract) (Mean ± SE) | Total phenolic content (μg GAE/mg extract) (Mean ± SE) |
|---|---|---|
| Yellow fraction (DAYF) | 101.88 ± 0.21a | 206.38 ± 0.96a |
| Green fraction (DAGF) | 49.30 ± 0.39c | 98.62 ± 0.16c |
| Light-green fraction (DALGF) | 79.73 ± 0.57b | 177.58 ± 0.14b |
| Dark-green fraction (DADGF) | 35.21 ± 0.57d | 74.80 ± 0.28d |
The values in a column with different letters are significantly different at p ≤ 0.05 (Duncan test, n = 3)
Antioxidant activity
The antioxidant activities of the four fractions were evaluated via the DPPH free-radical scavenging assay. The antioxidant activity of the fractions was varied, and the mean percentage of DPPH free-radical scavenging activity was calculated for concentrations ranging from 25 to 200 μg/ml. At a concentration of 200 μg/ml, the yellow fraction (DAYF) showed the highest percentage of DPPH free-radical scavenging activity by 83.24%, followed by the light-green fraction (DALGF), the green fraction (DAGF), and the dark-green fraction (DADGF) (Table 3). The results also revealed that the mean percentage of radical scavenging activity was increased with an increase in the concentration of the fractions.
Table 3.
Antioxidant activity of the methanol extract fractions determined via DPPH radical scavenging
| Fraction of methanol extract | Percentage of DPPH radical scavenging activity at different concentrations of fraction (μg/ml) (Mean ± SE) | IC50 (μg/ml) (Mean ± SE) | |||
|---|---|---|---|---|---|
| 25 | 50 | 100 | 200 | ||
| Yellow fraction (DAYF) | 22.58 ± 0.39 | 53.49 ± 0.56 | 76.98 ± 0.30 | 83.24 ± 0.44 | 63.73 ± 0.27a |
| Green fraction (DAGF) | 10.01 ± 0.39 | 16.93 ± 0.44 | 38.97 ± 0.25 | 51.66 ± 0.45 | 179.77 ± 1.05c |
| Light-green fraction (DALGF) | 21.55 ± 0.47 | 38.97 ± 0.44 | 57.19 ± 0.44 | 69.94 ± 0.53 | 105.79 ± 0.41b |
| Dark-green fraction (DADGF) | 10.74 ± 0.53 | 19.85 ± 0.39 | 35.82 ± 0.61 | 46.38 ± 0.52 | 204.28 ± 1.95d |
The values in a column of IC50 values with different letters are significantly different at p ≤ 0.05 (Duncan test, n = 3)
The IC50 values, which represent the concentration needed to scavenge 50% of the DPPH free radicals, varied significantly among the fractions. The DAYF had the lowest IC50 value at 63.73 μg/ml, indicating its high antioxidant activity. Conversely, DADGF had the highest IC50 value at 204.28 μg/ml, indicating lower antioxidant activity (Table 3).
Cytotoxicity activity
The cytotoxic effect of fractions on the HeLa, U2OS and normal cell lines varied across different concentrations (25–200 μg/ml). As the concentration of the fractions increased, a greater proportion of cell growth suppression was observed. For example, at a concentration of 200 μg/ml, the yellow fraction (DAYF) inhibited approximately 82.36% of the HeLa cells, followed by the light-green fraction (DALGF) inhibited 81.84% and the green fraction (DAGF) inhibited 79.07% (Table 4). Similarly, at 200 μg/ml, the dark-green fraction (DADGF) inhibited the growth of U2OS cells by 64.76%, whereas DALGF inhibited it by 60.59%.
Table 4.
Cytotoxic effects of the methanol extract fractions on different cell lines
| Fraction of methanol extract | Cell line | Percentage of cell growth inhibition at different concentrations of extract (μg/ml) (Mean ± SE) | IC50 (μg/ml) (Mean ± SE) | |||
|---|---|---|---|---|---|---|
| 25 | 50 | 100 | 200 | |||
| Yellow fraction (DAYF) | HeLa | 7.76 ± 5.27 | 25.32 ± 7.08 | 77.82 ± 0.37 | 79.07 ± 0.70 | 67.03 ± 2.39a |
| U2OS | 15.86 ± 6.31 | 23.22 ± 1.97 | 38.76 ± 1.53 | 46.20 ± 0.31 | 207.40 ± 6.44cc | |
| Normal | -7.33 ± 10.35 | 1.07 ± 6.28 | 5.27 ± 2.62 | 9.69 ± 2.67 | 1338.00 ± 38.16bbb* | |
| Green fraction (DAGF) | HeLa | 17.36 ± 9.59 | 23.02 ± 10.03 | 47.82 ± 8.29 | 82.36 ± 2.10 | 110.93 ± 14.20b |
| U2OS | 7.69 ± 2.41 | 22.16 ± 1.92 | 43.50 ± 2.16 | 58.38 ± 2.20 | 155.92 ± 4.37bb | |
| Normal | -16.56 ± 1.78 | -4.73 ± 3.57 | 6.26 ± 4.03 | 9.92 ± 15.38 | 997.78 ± 29.83aaa* | |
| Light-green fraction (DALGF) | HeLa | 10.13 ± 5.32 | 20.78 ± 4.54 | 67.50 ± 5.01 | 81.84 ± 2.27 | 78.00 ± 5.32a |
| U2OS | 13.00 ± 6.03 | 30.17 ± 2.58 | 47.83 ± 1.42 | 60.59 ± 5.34 | 142.93 ± 10.26bb | |
| Normal | 2.52 ± 4.96 | 7.25 ± 6.03 | 9.39 ± 1.77 | 13.51 ± 4.43 | 1686.11 ± 22.12ccc* | |
| Dark-green fraction (DADGF) | HeLa | 13.42 ± 14.62 | 16.77 ± 16.47 | 47.36 ± 9.94 | 78.15 ± 1.37 | 114.87 ± 19.05b |
| U2OS | 18.23 ± 5.15 | 32.05 ± 10.07 | 58.63 ± 1.53 | 64.76 ± 3.41 | 119.55 ± 4.61aa | |
| Normal | -12.67 ± 3.43 | 0.08 ± 6.29 | 4.27 ± 3.90 | 7.86 ± 8.98 | 1280.69 ± 29.24bbb* | |
The values in a column of IC50 values with different letters are significantly different at p ≤ 0.05 (Duncan test, n = 3), the values with a single letter indicate HeLa cells, the values with two letters indicate U2OS cells, the values with three letters indicate normal epithelial cell lines, and the values with an asterisk (*) in the IC50 of the normal cell line are significantly different from those of the other two cell lines at p ≤ 0.05 (Dunnett test, n = 3)
In contrast, treatment with methanol fractions had a minimal effect on the growth of normal cells, ranging from − 16.56 to 13.51%, indicating negligible cytotoxicity to normal human cells.
In terms of the IC50 values, DAYF and DALGF showed lower values of 67.03 μg/ml and 78.00 μg/ml, respectively, indicating significantly greater cytotoxicity against HeLa cells than DAGF and DADGF. For U2OS cells, DADGF had the lowest IC50 value of 119.55 μg/ml among the fractions, indicating its greater cytotoxicity. The IC50 values for normal cells were equal to or greater than 1000 μg/ml highlighting the significant non-toxicity of fractions to normal cells (Table 4).
Correlations between total phenolic/flavonoid contents and antioxidant/cell growth inhibition
The total phenolic and flavonoid contents of the methanol fractions were significantly correlated with the IC50 value of the antioxidant activity. The Pearson correlation coefficients of -0.987 and − 0.998 indicate a very strong negative relationship between the IC50 of antioxidant activity and the total phenolic/flavonoid contents (Table 5). This suggests that as the total phenolic and flavonoid contents of the fractions increase, the IC50 value of antioxidant activity decreases, indicating greater efficacy in scavenging DPPH radicals.
Table 5.
Correlations between independent variables (total phenolic and flavonoid contents) and dependent variables (antioxidant and cell growth inhibition capacity)
| Dependent variables | Independent variables | ||
|---|---|---|---|
| Total flavonoid content | Total phenolic content | ||
| IC50 of Antioxidant activity | Pearson correlation (r) | -0.998** | -0.987** |
| Sig. (2-tailed) | < 0.001 | < 0.001 | |
| N | 12 | 12 | |
| IC50 of HeLa cells growth inhibition | Pearson correlation (r) | -0.747** | -0.746** |
| Sig. (2-tailed) | 0.005 | 0.005 | |
| N | 12 | 12 | |
| IC50 of U2OS cells growth inhibition | Pearson correlation (r) | 0.800** | 0.701* |
| Sig. (2-tailed) | 0.002 | 0.011 | |
| N | 12 | 12 | |
| IC50 of Normal cells growth inhibition | Pearson correlation (r) | 0.476 | 0.556 |
| Sig. (2-tailed) | 0.117 | 0.061 | |
| N | 12 | 12 | |
* significant at p < 0.05; ** significant at p < 0.01
Furthermore, the total phenolic and flavonoid contents were strongly negatively correlated (r = -0.746/-0.747) with the IC50 values for the growth inhibition of HeLa cells highlighting their potent ability to inhibit HeLa cell growth. Conversely, these contents exhibited significantly strong positive correlations (r = 0.701/0.800) with the IC50 values for growth inhibition of U2OS cells. These findings indicate that higher phenolic and flavonoid contents increased the IC50 values, suggesting a moderate cytotoxic effect on U2OS cells. However, the phenolic and flavonoid contents showed a weakly positive (not significant) connection with the IC50 values for inhibiting the proliferation of normal cells, indicating that the phenolic and flavonoid contents had no significant impact on the growth of typical normal cell lines (Table 5).
Identified compounds in the yellow fraction
Altogether 27 compounds were identified in the yellow fraction (DAYF) (Table 6) and the chromatogram of the GC-MS is shown in Fig. 2. The major bioactive phenol derivatives (Fig. 3) detected in the DAYF were 2-methoxy-4-vinylphenol (1), 3,4-dimethoxy-phenol (2), 2-methoxy-4-(1-propenyl)-phenol (3), 2,6-dimethoxy-4-(2-propenyl)-phenol (4), 3-methoxy-1,2-benzenediol (5).
Table 6.
Identified compounds in the yellow fraction (DAYF) via GC-MS
| S.N. | Compound Name | RT (min) | Content % | Base m/z |
|---|---|---|---|---|
| 1 | 5-(Hydroxymethyl)-2-furancarboxaldehyde | 4.692 | 25.38 | 97.10 |
| 2 | 5-[3-(4-Methoxyphenyl)oxaziridin-2-yl]pentan-1-ol | 4.867 | 4.39 | 135.15 |
| 3 | 3-Methoxy-1,2-benzenediol | 4.957 | 0.98 | 78.05 |
| 4 | 2-Methoxy-4-vinylphenol | 5.176 | 1.42 | 150.20 |
| 5 | 3,4-Dimethoxy-phenol | 5.386 | 2.22 | 154.20 |
| 6 | 2-Methoxy-4-(1-propenyl)-phenol | 6.097 | 0.47 | 164.20 |
| 7 | 3’,5’-Dimethoxyacetophenone | 6.934 | 3.36 | 180.20 |
| 8 | Diethyl Phthalate | 7.090 | 0.20 | 149.15 |
| 9 | 2,6-Dimethoxy-4-(2-propenyl)-phenol | 7.949 | 0.87 | 194.15 |
| 10 | bis(2-Methylpropyl)-1,2-benzenedicarboxylic acid | 9.033 | 2.43 | 149.15 |
| 11 | n-Propargyloxycarbonyl-1-methionine-undecyl ester | 11.343 | 0.24 | 61.00 |
| 12 | Dansyl hydroxyl-1-proline | 11.387 | 0.39 | 44.95 |
| 13 | Octachloro-dibenzofuran | 11.620 | 0.48 | 48.00 |
| 14 | n-Tetracosanol-1 | 11.771 | 0.86 | 57.10 |
| 15 | Heptadecyl-oxirane | 12.603 | 0.24 | 43.05 |
| 16 | 3-[(Trimethylsilyl)oxy] propyl hexadecanoic acid | 12.887 | 0.22 | 43.05 |
| 17 | Tetratetracontane | 12.985 | 1.42 | 57.10 |
| 18 | Mono(2-ethylhexyl) 1,2-benzenedicarboxylic acid | 13.439 | 0.42 | 149.15 |
| 19 | Octacosyl trifluoroacetate | 13.639 | 0.71 | 57.10 |
| 20 | Heneicosane | 14.410 | 1.10 | 57.10 |
| 21 | n-Nonadecanol-1 | 14.451 | 0.98 | 69.10 |
| 22 | 1-Octacosanol | 15.102 | 0.66 | 57.10 |
| 23 | dl-.alpha.-Tocopherol succinate | 15.820 | 1.24 | 430.55 |
| 24 | 1-Heptacosanol | 15.892 | 6.92 | 57.10 |
| 25 | Octadecamethyl-cyclononasiloxane | 16.000 | 1.11 | 430.55 |
| 26 | Methyl (25rs)-3.beta.-acetoxy-5-cholesten-26-oate | 17.710 | 0.39 | 105.15 |
| 27 | Stigmast-5-en-3-ol, oleate | 18.066 | 1.69 | 147.20 |
Fig. 2.
Chromatogram of the yellow fraction (DAYF)
Fig. 3.
Molecular structure of phenol derivatives identified in the yellow fraction (DAYF)
2-methoxy-4-vinylphenol (1), 3,4-dimethoxy-phenol (2), 2-methoxy-4-(1-propenyl)-phenol (3), 2,6-dimethoxy-4-(2-propenyl)-phenol (4), 3-methoxy-1,2-benzenediol (5)
Discussion
The structure that bridges between an embryo and a seedling during seed germination in a nutrient medium is termed a protocorm. Orchid seeds, lacking endosperm and cotyledons, develop into protocorms before maturing into seedlings [19, 20]. Protocorms typically exhibit a globular or spherical shape and are often green or cream-yellow sometimes featuring foliaceous structures [21]. In the orchid life cycle, protocorms play a crucial role in serving as hosts for symbionts and eventually developing into shoot apical meristems [22, 23].
This study explored the influence of growth regulators such as BAP and coconut water on the multiplication efficiency of Dendrobium amoenum protocorms. BAP and coconut water significantly affect protocorm production because coconut water is rich in cytokinin which plays a significant role in cell division stages during the development of tissues in the protocorms [10–12, 15, 21, 24]. Thus, BAP and coconut water were added to the nutrient medium for crucial seed germination and subsequent development of protocorms [19, 21, 22].
The primary objective of the current study was to produce bioactive secondary metabolites in in-vitro-grown protocorms. Previous research has demonstrated the widespread production of bioactive secondary metabolites in the cells and tissues of in vitro-grown protocorms and plantlets [9, 12, 14, 15]. The synthesis of flavonoid and phenolic compounds in protocorms highlights the ability of plant genes to produce such molecules. The cytokinin in the nutrient medium affects the development of highly organised tissues and may favour the plant genes to produce secondary metabolites during multiplication and differentiation [25]. During the development of cells and tissues, phenolic compounds are synthesized via gene action [26, 27]. Previous studies evaluated the high concentrations of total phenol and flavonoid contents in Dendrobium stems [7, 28]. The methanol extract of D. amoenum, which is rich in bioactive flavonoid and phenol compounds, has demonstrated potent antioxidant and cytotoxic properties in previous studies [7, 8]. The ability of phenolic and flavonoid compounds to be synthesized in the plant tissue culture is supported by previous research on Dendrobium, making plant tissue culture an effective method for producing these compounds without relying on wild plants [9–14].
The yellow fraction of D. amoenum (DAYF) contains significant amounts of biologically active chemicals (Table 6) that potentially contribute to its antioxidant and anticancer properties [29–32]. Antioxidant-rich compounds, including flavonoid and phenol derivatives, play crucial roles in cancer chemoprevention [33]. Phenolic and flavonoid compounds from plants may inhibit cancer cell formation by altering the metabolic activation of carcinogens through xenobiotic-metabolizing enzymes, and certain flavonoids can influence hormone synthesis to suppress malignant cell growth [34, 35].
Conclusions
The full-strength solid MS medium supplemented with coconut water as well as liquid MS medium are effective for protocorm formation from seeds. The yellow fraction has the highest amount of total phenolic and flavonoid contents and has bioactive phenol derivatives. It effectively scavenges more than 50% of the DPPH radicals and significantly inhibits HeLa cell proliferation at low concentration. Importantly, it does not harm normal epithelial cells. Protocorms could serve as a source of bioactive secondary metabolites to pave out their potential in antioxidants and anticancers.
Acknowledgements
The authors express their gratitude to Mr. Tej Lal Chaudhary, Ms. Lasta Maharjan and Mr. Anil Shah for their assistance with the laboratory work.
Abbreviations
- BAP
6-Benzylaminopurine
- CW
Coconut water
- DADGF
Dark-green fraction
- DAGF
Green fraction
- DALGF
Light-green fraction
- DAYF
Yellow fraction
- DPPH
2,2-Diphenyl-1-picrylhydrazyl
- FMS
Full-strength Murashige and Skoog medium
- GAE
Gallic acid equivalent
- GC-MS
Gas chromatography and mass spectrometry
- HeLa
Human cervical cancer cell line
- HMS
Half-strength Murashige and Skoog medium
- IC50
Half-maximal inhibitory concentration
- LMS
Liquid Murashige and Skoog medium
- MS
Murashige and Skoog medium
- QE
Quercetin equivalent
- U2OS
Human osteosarcoma cell line
Author contributions
M.R.P. did conceptualization of the research and methodology, analyzed and interpreted data, and wrote manuscript draft; S.S. did laboratory investigation and wrote manuscript draft; P.R.J. did laboratory investigation; B.P. managed laboratory resources; S.H.W. managed resources and contributed in editing manuscript; P.G. managed laboratory resources; K.P. managed laboratory resources; B.P. did project administration and funding acquisition. All authors read and approved the final manuscript.
Funding
This work was supported by the University Grants Commission, Nepal (Grant No. CRG/077–078/S&T-4). The funder has no role in the conceptualization, design, data collection, analysis, or decision to prepare and publish the manuscript.
Data availability
All data generated or analysed during this study are included in this published article.
Declarations
Ethics approval and consent to participate
The permission for the plant collection was obtained from the Department of Forest and Soil Conservation of the Ministry of Forest and Environment, Government of Nepal (Reference No.: 334 − 079/80).
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Clinical trial number
Not applicable.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.WCSP. World Checklist of Selected Plant Families. https://wcsp.science.kew.org/. Retrieved 12 April 2020.
- 2.Rokaya MB, Raskoti BB, Timsina B, Münzbergová Z. An annotated checklist of the orchids of Nepal. Nord J Bot. 2013;31(5):511–50. [Google Scholar]
- 3.Pant B, Raskoti BB. Medicinal orchids of Nepal. Himalayan Map House; 2013.
- 4.Majumder PL, Bandyopadhyay S. Stilbenoids and sesquiterpene derivatives of the orchids Gastrochilum calcoelaria and Dendrobium amoenum: application of 2D NMR spectroscopy in structural elucidation of complex natural products. Indian J Chem Soc. 2010;41(51):221–34. [Google Scholar]
- 5.Majumder PL, Guha S, Sen S. Bibenzyl derivatives from the orchid Dendrobium Amoenum. Phytochemistry. 1999;52(7):1365–9. [Google Scholar]
- 6.Venkateswarlu S, Raju MS, Subbaraju GV. Synthesis and biological activity of isoamoenylin, a metabolite of Dendrobium amoenum. Bioscience, Biotechnology and Biochemistry. 2002;66(10):2236-8. [DOI] [PubMed]
- 7.Paudel MR, Chand MB, Karki N, Pant B. Antioxidant activity and total phenolic and flavonoid contents of Dendrobium amoenum Wall. ex Lindl. Botanica Orientalis: Journal of Plant Science. 2015;9:20–6.
- 8.Paudel MR, Pant B. Cytotoxic activity of crude extracts of Dendrobium amoenum and detection of bioactive compounds by GC-MS. Botanica Orientalis: Journal of Plant Science. 2017;11:38–42.
- 9.Lin W, Wang J, Xu X, Wu Y, Qiu D, He B, Sarsaiya S, Ma X, Chen J. Rapid propagation in vitro and accumulation of active substances of endangered Dendrobium Cariniferum Rchb. F. Bioengineered. 2020;11(1):386–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Pant B, Chand K, Paudel MR, Joshi PR, Thapa BB, Park SY, Shakya S, Thakuri LS, Rajbahak S, Sah AK, Baniya MK. Micropropagation, antioxidant and anticancer activity of pineapple orchid: Dendrobium Densiflorum Lindl. J Plant Biochem Biotechnol. 2022;31:399–409. [Google Scholar]
- 11.Pant B, Joshi PR, Maharjan S, Thakuri LS, Pradhan S, Shah S, Wagner SH, Pant B. Comparative cytotoxic activity of wild harvested stems and in vitro-raised protocorms of Dendrobium Chryseum Rolfe in human cervical carcinoma and glioblastoma cell lines. Adv Pharmacol Pharm Sci. 2021;2021(1):8839728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Paudel MR, Joshi PR, Chand K, Sah AK, Acharya S, Pant B, Pant B. Antioxidant, anticancer and antimicrobial effects of in vitro developed protocorms of Dendrobium Longicornu. Biotechnol Rep. 2020;28:e00527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Espinosa-Leal CA, Puente-Garza CA, García-Lara S. In vitro plant tissue culture: means for production of biological active compounds. Planta. 2018;248:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Park CM, Kwon JC, Han NK, Joung MS, Paek KY, Choi JW. Comparative study of protocorm-like body and multiple shoots from Dendrobium candidum on biological activities. J Soc Cosmet Scientists Korea. 2014;40(1):29–36. [Google Scholar]
- 15.Park SY, Ho TT, Paek KY. Medicinal orchids: production of bioactive compounds and biomass. Orchid Biology: Recent Trends & Challenges; 2020. pp. 439–50. [Google Scholar]
- 16.Bajwa MN, Khanum M, Zaman G, Ullah MA, Farooq U, Waqas M, Ahmad N, Hano C, Abbasi BH. Effect of wide-spectrum monochromatic lights on growth, phytochemistry, nutraceuticals, and antioxidant potential of in-vitro callus cultures of Moringa oleifera. Molecules. 2023;28(3):1497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bajwa MN, Zaman G, Ullah MA, Javed MU, Andleeb A, Hano C, Abbasi BH. Effect of differential exposure of UV-C and melatonin stress on the therapeutic potential of bioactive compounds in Moringa oleifera. South Afr J Bot. 2024;175:363–72. [Google Scholar]
- 18.Mansour RB, Jilani IB, Bouaziz M, Gargouri B, Elloumi N, Attia H, Ghrabi-Gammar Z, Lassoued S. Phenolic contents and antioxidant activity of ethanolic extract of Capparis spinosa. Cytotechnology. 2016;68:135–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Yeung EC. The orchid embryo—An embryonic protocorm. Botany. 2022;100(9):691–706. [Google Scholar]
- 20.Zhao DK, Selosse MA, Wu L, Luo Y, Shao SC, Ruan YL. Orchid reintroduction based on seed germination-promoting mycorrhizal fungi derived from protocorms or seedlings. Front Plant Sci. 2021;12:701152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gao X, Wang Y, Deng D, Luo Y, Shao S, Luo Y. Morphogenesis changes in protocorm development during symbiotic seed germination of Dendrobium chrysotoxum (Orchidaceae) with its mycobiont, Tulasnella Sp. Horticulturae. 2023;9(5):531. [Google Scholar]
- 22.Yeung EC. A perspective on orchid seed and protocorm development. Bot Stud. 2017;58(1):33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yeung EC, Li YY, Lee YI. An overview of the life of an orchid protocorm - a developmental perspective. InIII International Orchid Symposium 1262. 2018:13–22.
- 24.Sharma R, De KK, Sharma B, Majumdar S. Micropropagation of Dendrobium Fimbriatum Hook. By green pod culture. J Plant Biology. 2005;48:253–7. [Google Scholar]
- 25.Bhattacharyya P, Kumaria S, Diengdoh R, Tandon P. Genetic stability and phytochemical analysis of the in vitro regenerated plants of Dendrobium Nobile Lindl., an endangered medicinal orchid. Meta Gene. 2014;2:489–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wu B, He S, Pan YJ. New dihydrodibenzoxepins from Bulbophyllum kwangtungense. Planta Med. 2006;72(13):1244–7. [DOI] [PubMed] [Google Scholar]
- 27.Li YM, Wang HY, Liu GQ. Erianin induces apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin. 2001;22(11):1018–22. [PubMed] [Google Scholar]
- 28.Singh CB, Devi MC, Thokchom DS, Sengupta M, Singh AK. Phytochemical screening, estimation of total phenols, total flavonoids and determination of antioxidant activity in the methanol extract of Dendrobium denudans D. Don stems. J Pharmacognosy Phytochemistry. 2015;4(4):06–11. [Google Scholar]
- 29.Wang G, Wang J, Deng Y, Qin L, He Y, Tan D. Chemical constituents and nutritional health functions of Dendrobium nobile: a review. Food Sci Technol. 2022;42:e84522. [Google Scholar]
- 30.Śliwiński T, Kowalczyk T, Sitarek P, Kolanowska M. Orchidaceae-derived anticancer agents: a review. Cancers. 2022;14(3):754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.He L, Su Q, Bai L, Li M, Liu J, Liu X, Zhang C, Jiang Z, He J, Shi J, Huang S. Recent research progress on natural small molecule bibenzyls and its derivatives in Dendrobium species. Eur J Med Chem. 2020;204:112530. [DOI] [PubMed] [Google Scholar]
- 32.Tanagornmeatar K, Chaotham C, Sritularak B, Likhitwitayawuid K, Chanvorachote P. Cytotoxic and anti-metastatic activities of phenolic compounds from Dendrobium Ellipsophyllum. Anticancer Res. 2014;34(11):6573–9. [PubMed] [Google Scholar]
- 33.Dai J, Mumper RJ. Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules. 2010;15(10):7313–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Gali-Muhtasib H, Hmadi R, Kareh M, Tohme R, Darwiche N. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis. 2015;20:1531–62. [DOI] [PubMed] [Google Scholar]
- 35.Chen Y, Lu CJ, Xue LP. Validation of HEM-based cavitation for cavitation flows around disk. In: New Trends in Fluid Mechanics Research: Proceedings of the Fifth International Conference on Fluid Mechanics (Shanghai, 2007). 2007; pp.352–355. Springer Berlin Heidelberg.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data generated or analysed during this study are included in this published article.





